{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:15:04Z","timestamp":1768569304834,"version":"3.49.0"},"posted":{"date-parts":[[2025,2,5]]},"group-title":"Neurology","reference-count":49,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,2,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>INTRODUCTION<\/jats:title>\n                  <jats:p>Cerebrospinal fluid (CSF) biomarkers of Alzheimer\u2019s disease (AD) are reliable predictors of future AD risk. We investigated whether pre-clinical changes in AD CSF biomarkers are reflected in blood DNA methylation (DNAm) levels in cognitively normal participants.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We profiled blood-based DNAm with the EPIC array in participants without a diagnosis of cognitive impairment in the Emory Healthy Brain Study (EHBS; N=495) and ADNI (N=122). Their CSF A\u03b242, tTau, and pTau levels were quantified using Elecsys immunoassays. We conducted epigenome-wide association studies to assess associations between DNAm and CSF biomarkers of AD.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>In EHBS, no loci were Bonferroni-significant after adjusting for confounding factors. In ADNI, two loci were significant, but they were not replicated in EHBS. There was little agreement between the top loci from EHBS and ADNI.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>DISCUSSION<\/jats:title>\n                  <jats:p>Our study showed little evidence of an association between differential blood-based DNAm and pre-clinical AD CSF biomarkers.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.02.04.25321657","type":"posted-content","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T19:45:18Z","timestamp":1738784718000},"source":"Crossref","is-referenced-by-count":1,"title":["Epigenome-wide association study of cerebrospinal fluid-based biomarkers of Alzheimer\u2019s disease in cognitively normal individuals"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6005-417X","authenticated-orcid":false,"given":"Anke","family":"H\u00fcls","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaini","family":"Konwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen N.","family":"Conneely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan I.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Lah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliza P.","family":"Wingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas S.","family":"Wingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025020623551338000_2025.02.04.25321657v1.1","unstructured":"Jiaquan Xu , Sherry L. Murphy , Kenneth D. Kochanek , Elizabeth Arias . Mortality in the United States, 2018. NCHS Data Brief [Internet]. 2020 Jan;no 355. Available from: https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db355.htm"},{"key":"2025020623551338000_2025.02.04.25321657v1.2","doi-asserted-by":"publisher","DOI":"10.1002\/ALZ.12328"},{"key":"2025020623551338000_2025.02.04.25321657v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"2025020623551338000_2025.02.04.25321657v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02476-4"},{"key":"2025020623551338000_2025.02.04.25321657v1.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2004.01368.x"},{"key":"2025020623551338000_2025.02.04.25321657v1.6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.167791"},{"key":"2025020623551338000_2025.02.04.25321657v1.7","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.55"},{"issue":"10","key":"2025020623551338000_2025.02.04.25321657v1.8","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/acn3.643","article-title":"Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory","volume":"5","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"2025020623551338000_2025.02.04.25321657v1.9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00259-015-3170-y","article-title":"Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting","volume":"43","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025020623551338000_2025.02.04.25321657v1.10","doi-asserted-by":"crossref","unstructured":"Weymouth L , Smith AR , Lunnon K. DNA Methylation in Alzheimer\u2019s Disease. In Berlin, Heidelberg: Springer Berlin Heidelberg; 2024 [cited 2024 Nov 21]. (Current Topics in Behavioral Neurosciences). Available from: https:\/\/link.springer.com\/10.1007\/7854_2024_530","DOI":"10.1007\/7854_2024_530"},{"key":"2025020623551338000_2025.02.04.25321657v1.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23243-4"},{"key":"2025020623551338000_2025.02.04.25321657v1.12","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt451"},{"key":"2025020623551338000_2025.02.04.25321657v1.13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002698"},{"key":"2025020623551338000_2025.02.04.25321657v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.01.017"},{"issue":"1","key":"2025020623551338000_2025.02.04.25321657v1.15","first-page":"27","article-title":"DNA Methylation Profiles of Selected Pro-Inflammatory Cytokines in Alzheimer Disease","volume":"76","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"key":"2025020623551338000_2025.02.04.25321657v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2021.01.015"},{"key":"2025020623551338000_2025.02.04.25321657v1.17","doi-asserted-by":"crossref","unstructured":"Acha B , Corroza J , S\u00e1nchez-Ruiz De Gordoa J , Cabello C , Robles M , M\u00e9ndez-L\u00f3pez I , et al. Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease: A Potential Diagnostic Approach. Neurology [Internet]. 2023 Dec 5 [cited 2024 Jul 15];101(23). Available from: https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0000000000207865","DOI":"10.1212\/WNL.0000000000207865"},{"key":"2025020623551338000_2025.02.04.25321657v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2020.06.023"},{"key":"2025020623551338000_2025.02.04.25321657v1.19","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0755-5"},{"key":"2025020623551338000_2025.02.04.25321657v1.20","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0729-7"},{"issue":"1","key":"2025020623551338000_2025.02.04.25321657v1.21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13195-023-01216-7","article-title":"Distinct CSF biomarker-associated DNA methylation in Alzheimer\u2019s disease and cognitively normal subjects","volume":"15","year":"2023","journal-title":"Alz Res Therapy"},{"key":"2025020623551338000_2025.02.04.25321657v1.22","first-page":"alz.14098","article-title":"Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer\u2019s disease in the EMIF-AD study","volume":"28","year":"2024","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"2025020623551338000_2025.02.04.25321657v1.23","doi-asserted-by":"publisher","DOI":"10.1159\/000501856"},{"key":"2025020623551338000_2025.02.04.25321657v1.24","unstructured":"ADNI Procedures Manual [Internet]. Available from: https:\/\/adni.loni.usc.edu\/wp-content\/uploads\/2008\/07\/adni2-procedures-manual.pdf"},{"key":"2025020623551338000_2025.02.04.25321657v1.25","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181c47cc2"},{"key":"2025020623551338000_2025.02.04.25321657v1.26","unstructured":"L. M. Shaw , J. Q. Trojanowski . for the Alzheimer\u2019s Disease Neuroimaging Initiative, Methods Report, ADNI3: Batch analyses of Ab42, t-tau, and p-tau181 in ADNI1, GO, 2 CSF samples using the fully automated Roche Elecsys and cobas e immunoassay analyzer system [Internet]. Available from: https:\/\/adni.loni.usc.edu\/wp-content\/uploads\/2018\/04\/PPT-set-102-PPSB-FTF-Boston-10-31-2017.pptx"},{"issue":"1","key":"2025020623551338000_2025.02.04.25321657v1.27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13072-021-00428-1","article-title":"Risk-focused differences in molecular processes implicated in SARS-CoV-2 infection: corollaries in DNA methylation and gene expression","volume":"14","year":"2021","journal-title":"Epigenetics & Chromatin"},{"issue":"1","key":"2025020623551338000_2025.02.04.25321657v1.28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/14616734.2021.1938872","article-title":"Associations of peripheral blood DNA methylation and estimated monocyte proportion differences during infancy with toddler attachment style","volume":"25","year":"2023","journal-title":"Attach Hum Dev"},{"key":"2025020623551338000_2025.02.04.25321657v1.29","unstructured":"Kober Lab [Internet]. Available from: https:\/\/github.com\/kobor-lab"},{"issue":"1","key":"2025020623551338000_2025.02.04.25321657v1.30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13148-018-0504-1","article-title":"Identifying mislabeled and contaminated DNA methylation microarray data: an extended quality control toolset with examples from GEO","volume":"10","year":"2018","journal-title":"Clin Epigenet"},{"key":"2025020623551338000_2025.02.04.25321657v1.31","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu049"},{"key":"2025020623551338000_2025.02.04.25321657v1.32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-293"},{"key":"2025020623551338000_2025.02.04.25321657v1.33","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1066-1"},{"key":"2025020623551338000_2025.02.04.25321657v1.34","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt090"},{"issue":"10","key":"2025020623551338000_2025.02.04.25321657v1.35","first-page":"e2235068","article-title":"Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry","volume":"5","year":"2022","journal-title":"Vascular Comorbidities, and Neighborhood Factors. JAMA Netw Open"},{"issue":"3","key":"2025020623551338000_2025.02.04.25321657v1.36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ana.26960","article-title":"Lower Prevalence of Asymptomatic Alzheimer\u2019s Disease Among Healthy African Americans","volume":"96","year":"2024","journal-title":"Annals of Neurology"},{"key":"2025020623551338000_2025.02.04.25321657v1.37","unstructured":"Lucas A. DC. FlowSorted.Blood.EPIC [Internet]. Bioconductor; 2018 [cited 2024 Jun 20]. Available from: https:\/\/bioconductor.org\/packages\/FlowSorted.Blood.EPIC"},{"key":"2025020623551338000_2025.02.04.25321657v1.38","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq340"},{"key":"2025020623551338000_2025.02.04.25321657v1.39","doi-asserted-by":"crossref","unstructured":"Suderman M , Staley JR , French R , Arathimos R , Simpkin A , Tilling K. dmrff: identifying differentially methylated regions efficiently with power and control [Internet]. 2018 [cited 2024 Jun 21]. Available from: http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/508556","DOI":"10.1101\/508556"},{"key":"2025020623551338000_2025.02.04.25321657v1.40","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2020-0344"},{"issue":"1","key":"2025020623551338000_2025.02.04.25321657v1.41","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41398-019-0376-y","article-title":"Genome-wide DNA methylation comparison between live human brain and peripheral tissues within individuals","volume":"9","year":"2019","journal-title":"Transl Psychiatry"},{"key":"2025020623551338000_2025.02.04.25321657v1.42","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btv560"},{"issue":"11","key":"2025020623551338000_2025.02.04.25321657v1.43","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41380-017-0008-y","article-title":"Meta-analysis of epigenome-wide association studies of cognitive abilities","volume":"23","year":"2018","journal-title":"Mol Psychiatry"},{"key":"2025020623551338000_2025.02.04.25321657v1.44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19791-w"},{"issue":"1","key":"2025020623551338000_2025.02.04.25321657v1.45","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40478-021-01177-8","article-title":"Sex-specific DNA methylation differences in Alzheimer\u2019s disease pathology","volume":"9","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"2025020623551338000_2025.02.04.25321657v1.46","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-00968-0"},{"issue":"1","key":"2025020623551338000_2025.02.04.25321657v1.47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13148-019-0622-4","article-title":"DNA methylome profiling of all-cause mortality in comparison with age-associated methylation patterns","volume":"11","year":"2019","journal-title":"Clin Epigenetics"},{"key":"2025020623551338000_2025.02.04.25321657v1.48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004211"},{"issue":"5","key":"2025020623551338000_2025.02.04.25321657v1.49","doi-asserted-by":"crossref","first-page":"e0127574","DOI":"10.1371\/journal.pone.0127574","article-title":"Parathyroid hormone, cognitive function and dementia: a systematic review","volume":"10","year":"2015","journal-title":"PLoS One"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.02.04.25321657","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:27:17Z","timestamp":1768508837000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2025.02.04.25321657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":49,"URL":"https:\/\/doi.org\/10.1101\/2025.02.04.25321657","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1002\/alz.70318","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,2,5]]},"subtype":"preprint"}}